Vistin Pharma ASA: Second quarter and YTD 2026 financial results

Barchart · 2d ago

Oslo, Norway, 20 August 2026

Vistin Pharma ASA (VISTN) today announces its financial results for the second quarter and first half of 2026.

Revenue in the second quarter amounted to MNOK 100, compared to MNOK 118 in Q2 2025. Sales volume increased by 8%, offset by a significantly stronger NOK against EUR in the quarter compared to 2025, impacting sales in local currency.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.